Showing results (191-200 of 315) with videos related to
Sort By:
Pageof 32
European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantationMaximilian Merz, Lina Jansen, Felipe A Castro, et al.Blood|December 4, 2012
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow TransplantationDamien Roos-Weil, Sascha Dietrich, Ariane Boumendil, et al.British Journal of Haematology|February 23, 2018
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.Blood Cancer Journal|May 2, 2024
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patientsAnn-Kristin Schmälter, Maud Ngoya, Jacques-Emmanuel Galimard, et al.Blood Advances|September 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AMLJulia M Unglaub, Richard F Schlenk, Jan Moritz Middeke, et al.Blood|February 26, 2013
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trialPeter Dreger, Andrea Schnaiter, Thorsten Zenz, et al.Blood Advances|August 30, 2024
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party studySimon Renders, Maud Ngoya, Herve Finel, et al.Leukemia|August 27, 2024
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 studyPatrick Derigs, Maria-Luisa Schubert, Peter Dreger, et al.Transplantation and Cellular Therapy|April 13, 2026
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patientsJochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantationCelso A Rodrigues, Guillermo Sanz, Claudio G Brunstein, et al.Pageof 32